secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dare Bioscience, Inc. (DARE)
CIK:        0001401914
Form:       8-K
Filed at:   2026-08-17T12:35:37+00:00
Accession:  0001493152-26-038649
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Daré Bioscience prices $6.0M registered direct offering at $1.37/share
----------------------------------------------------------------------

- Offering of 4,379,581 shares (or pre-funded warrants) at $1.37/share; gross proceeds ~$6.0M.
- Concurrent private placement of Series A and B warrants for up to 4,379,581 shares each, exercise price $1.37, subject to stockholder approval.
- Closing expected on or about August 17, 2026; Ladenburg Thalmann acting as exclusive placement agent.
- Proceeds to fund working capital, 503B compounding, consumer health strategies, R&D, and general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401914/000149315226038649/0001493152-26-038649-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401914/000149315226038649/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-038649

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer